CD274 and metastatic neoplasm: Patients with locally advanced or metastatic disease had PD-L1-positive tumors (determined by mRNA expression) more frequently compared to subjects with less advanced disease stages (23/92 (25%) vs. 11/94 (11.7%), p = 0.023), while no statistically significant associations were found for other analyzed parameters (age, gender, tumor location).